Investor Presentaiton

Manufacturing footprint - Enabling Customers with Integrated capabilities Visakhapatnam Parawada API CDMO Hyderabad Bangalore U1 U3 U5 LSPL U1 Sriam Lab R1 R2 API CDMO^ API CDMO API Intermediates Bio-Ingredients Bio-Ingredients 336 R1 1,256 KL 296 R & R&D 2,317 KL 53 R 161 KL 42 R3 AGR² 139 KL 31 R 81 KL Atchutapuram U2 U4 U6 FDF API API CDMO API Intermediates 10Bn units, 12 R 89 KL 212 R 112 R 2,001 KL 1479 KL FDA Pmda US Food and Drug Admin Australian Government Kilo Lab API CDMO 43 R + R&D block 4.3 KL Department of Health and Aged Care Therapeutic Goods Administration World Health Organization MHRA EUROPEAN MEDICINES AGENCY SCIENCE MEDICINES HEALTH Regulating Medicines and Medical Devices * Fermentation Capacity in Ltr 1 Reactors 2 All Glass line Reactors ^ Hormone and Steroid facility 26 Laurus Q2 & H1 FY 2024 Investor Presentation | October 20, 2023 LAURU 5 Fermenters & R&D 10 KL * 4 Fermenters 180 KL* 7.5 Million Lts Reactor Volumes 190 Kilo Lts Fermentation Capacity 11 Sites including R&D API/Drug Substance: 8 CDMO: 5 FDF: 1 Bio-Ingredients: 2 LAURUS Labs Knowledge. Innovation. Excellence

View entire presentation